📰 Alexander Egeberg News
Alexander Egeberg News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alexander Egeberg. Real-time updates on events, politics, business and more.
February 28, 2024
Joint pain and itch were key culprits, according to a cross-sectional analysis of Danish data.
October 13, 2023
Oral roflumilast not only appears to improve skin symptoms, but it could also help with weight loss, results of the phase 2 PSORRO study suggest.
October 9, 2023
BALLERUP, Denmark, October 09, 2023--Globally known professor and dermatologist joins LEO Pharma
August 31, 2023
Psoriasis wasn't associated with higher risk of heart attacks or strokes when people with the skin condition didn't have a family history of cardiovascular disease, the study found.
April 4, 2023
A set of highlights from some of the impactful breakthroughs covered in dermatology this past month, including phase 3 trial data bimekizumab, tapinarof, and other treatments.
March 25, 2023
A new oral phosphodiesterase-4 (PDE4) inhibitor achieved impressive rates of complete or near-complete skin clearance in a phase 2 study that also found the drug was well tolerated.
March 22, 2023
New late-breaking data showed that oral roflumilast treatment was both safe and efficacious against psoriasis, making it a potentially less expensive and convenient treatment alternative.